Indian pharma leaders seek faster trials, state-backed market for new drugs
Kiran Mazumdar-Shaw flags regulatory delays; Glenmark's Glenn Saldanha calls for reimbursement support for life-saving medicines
Attribution
This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.
Read on Business Today